GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » LT-Debt-to-Total-Asset

Curative Biosciences (Curative Biosciences) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Curative Biosciences's long-term debt to total assests ratio for the quarter that ended in Mar. 2018 was 0.00.

Curative Biosciences's long-term debt to total assets ratio stayed the same from Mar. 2017 (0.00) to Mar. 2018 (0.00).


Curative Biosciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Curative Biosciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences LT-Debt-to-Total-Asset Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Curative Biosciences LT-Debt-to-Total-Asset Calculation

Curative Biosciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2017 is calculated as

LT Debt to Total Assets (A: Jun. 2017 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2017 )/Total Assets (A: Jun. 2017 )
=0/0.002
=

Curative Biosciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2018 is calculated as

LT Debt to Total Assets (Q: Mar. 2018 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2018 )/Total Assets (Q: Mar. 2018 )
=0/0.014
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biosciences  (OTCPK:CBDX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Curative Biosciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines